María Natalia Gandur Quiroga: Unveiling New Players in the Tumor Microenvironment: Tumor-Resident Microbes

María Natalia Gandur Quiroga shared a post on LinkedIn:

“Unveiling New Players in the Tumor Microenvironment: Tumor-Resident Microbes (TRM)
Key Takeaways from “Tumor-resident microbes: the new kids on the microenvironment block”:

Fundamental Role:TRMs are crucial components of the tumor microenvironment, influencing tumor growth, distant dissemination, and response to therapies. Technological Advances: Recent advancements in technology are enhancing the identification and visualization of cell type-specific microbes within the TME.

Therapeutic Target: Understanding the role of TRMs opens new perspectives for targeting microbes or utilizing microbial interventions in cancer interception or therapy.

Impact on Metastasis and Immunity: TRMs can facilitate metastasis and alter the body’s immune response to cancer, affecting treatment efficacy. Therapeutic Strategies: Exploration of prebiotics, probiotics, and fecal microbiome transfers as potential enhancements to immunotherapy and chemotherapy.

This study highlights the emerging importance of microbes in cancer development and treatment, marking a promising advancement in oncological research.”

Source: María Natalia Gandur Quiroga/LinkedIn

Maria Natalia Gandur Quiroga is a Medical Oncologist and Chief of the Division of Genitourinary Medical Oncology at the Instituto de Oncología Ángel H. Roffo in Buenos Aires, Argentina. She is a Professor of Medicine at the University of Buenos Aires at the Oncologists Post Graduates Studies. Her research focuses on clinical trials with aims to improve the treatment of patients with urologic tumors.  She is an active member of the European Association for Cancer Research, Argentinian Medical Association and American Society of Clinical Oncology.